Unknown

Dataset Information

0

Immunotherapy in ovarian cancer.

ABSTRACT: Ovarian cancer is the most deadly gynecologic malignancy, with more than 15,000 deaths anticipated in 2012. While approximately 80% of patients will respond to frontline chemotherapy, more than 60% of patients will experience disease recurrence and only 44% will be alive at 5 y. Host anti-tumor immune responses are associated with a significant improvement in overall survival for women with ovarian cancer. By bolstering these responses, it may therefore be possible to significantly influence the prognosis of women with this lethal disease. In this review, we will focus on innovative immune-based strategies which are currently being investigated in the treatment of ovarian cancer.

SUBMITTER: Mantia-Smaldone GM 

PROVIDER: S-EPMC3579897 | biostudies-literature | 2012 Sep

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Immunotherapy in ovarian cancer.

Mantia-Smaldone Gina M GM   Corr Bradley B   Chu Christina S CS  

Human vaccines & immunotherapeutics 20120821 9

Ovarian cancer is the most deadly gynecologic malignancy, with more than 15,000 deaths anticipated in 2012. While approximately 80% of patients will respond to frontline chemotherapy, more than 60% of patients will experience disease recurrence and only 44% will be alive at 5 y. Host anti-tumor immune responses are associated with a significant improvement in overall survival for women with ovarian cancer. By bolstering these responses, it may therefore be possible to significantly influence the  ...[more]

Similar Datasets

Unknown Immunotherapy for ovarian cancer.
| S-EPMC4355232 | biostudies-literature
Unknown Immunotherapy in ovarian cancer.
| S-EPMC5834124 | biostudies-literature
Unknown Adoptive immunotherapy against ovarian cancer.
| S-EPMC4869278 | biostudies-literature
Unknown Opportunities in immunotherapy of ovarian cancer.
| S-EPMC4852275 | biostudies-literature
Unknown Immunotherapy Advances for Epithelial Ovarian Cancer.
| S-EPMC7764119 | biostudies-literature
Unknown Ovarian Cancer Immunotherapy and Personalized Medicine.
| S-EPMC8234871 | biostudies-literature
Unknown Application Of Adoptive Immunotherapy In Ovarian Cancer.
| S-EPMC6775498 | biostudies-literature
Unknown Ovarian Cancer Immunotherapy: Turning up the Heat.
| S-EPMC6628106 | biostudies-literature
Unknown Antigen-specific active immunotherapy for ovarian cancer.
| S-EPMC6513204 | biostudies-literature
Unknown Ovarian Cancer Immunotherapy: Preclinical Models and Emerging Therapeutics.
| S-EPMC6115831 | biostudies-literature